The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.

Hypoxia-inducible factor-1 (HIF) is regulated by oxygen-dependent prolyl hydroxylation. Of the three HIF prolyl hydroxylases (PHD1, 2 and 3) identified, PHD3 exhibits restricted substrate specificity in vitro and is induced in different cell types by diverse stimuli. PHD3 may therefore provide an in...

Descripció completa

Dades bibliogràfiques
Autors principals:	Masson, N, Appelhoff, R, Tuckerman, JR, Tian, Y, Demol, H, Puype, M, Vandekerckhove, J, Ratcliffe, P, Pugh, C
Format:	Journal article
Idioma:	English
Publicat:	2004

Ítems similars

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
per: McNeill, L, et al.
Publicat: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
per: Tuckerman, JR, et al.
Publicat: (2004)

Assembly and substrate recognition properties of human CCT subunits of the TRiC chaperonin
per: Sergeeva, Oksana A
Publicat: (2015)

Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
per: Appelhoff, R, et al.
Publicat: (2004)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
per: Tian, Y, et al.
Publicat: (2006)

Regulation of HIF: prolyl hydroxylases.
per: Stolze, I, et al.
Publicat: (2006)

The chaperonin TRiC forms an oligomeric complex in the malaria parasite cytosol
per: Spillman, Natalie J., et al.
Publicat: (2018)

Structural and functional characterisation of the group II chaperonin CCT/TRiC
per: Kelly, J
Publicat: (2020)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
per: Cockman, M, et al.
Publicat: (2019)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
per: Schlemminger, I, et al.
Publicat: (2003)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
per: Masson, N, et al.
Publicat: (2003)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
per: Mole, D, et al.
Publicat: (2003)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
per: Chowdhury, R, et al.
Publicat: (2016)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
per: Chan, M, et al.
Publicat: (2016)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
per: Astuti, D, et al.
Publicat: (2010)

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
per: Astuti, D, et al.
Publicat: (2011)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
per: Hewitson, K, et al.
Publicat: (2007)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
per: Yeh, TL, et al.
Publicat: (2017)

Substrate selectivity of prolyl hydroxylases
per: McDonough, M
Publicat: (2018)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
per: Chowdhury, R, et al.
Publicat: (2013)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
per: Willam, C, et al.
Publicat: (2006)

Synthesis And Characterization Of Potential Human Hypoxia Inducible Factor (Hif) Prolyl Hydroxylase Domain 2 (Phd-2) Inhibitors
per: Toh, Lee Roy
Publicat: (2021)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
per: Giatromanolaki, A, et al.
Publicat: (2008)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway
per: Giatromanolaki, A, et al.
Publicat: (2008)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
per: Holt-Martyn, JP, et al.
Publicat: (2019)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
per: Wijeyekoon, JB
Publicat: (2013)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
per: Yeoh, K, et al.
Publicat: (2013)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
per: Richardson, NL, et al.
Publicat: (2021)

Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice.
per: Walmsley, SR, et al.
Publicat: (2011)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
per: Lippl, K
Publicat: (2018)

Hyperplasia of pulmonary neuroepithelial bodies (NEB) in lungs of prolyl hydroxylase -1(PHD-1) deficient mice
per: Pan, J, et al.
Publicat: (2012)

Hyperplasia of pulmonary neuroepithelial bodies (NEB) in lungs of prolyl hydroxylase -1(PHD-1) deficient mice.
per: Pan, J, et al.
Publicat: (2012)

Hyperplasia of Pulmonary Neuroepithelial Bodies (NEB) in Lungs of Prolyl Hydroxylase-1(PHD-1) Deficient Mice
per: Pan, J, et al.
Publicat: (2012)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
per: Lippl, K, et al.
Publicat: (2015)

Oxygen sensing by HIF hydroxylases.
per: Schofield, C, et al.
Publicat: (2004)

Signalling hypoxia by HIF hydroxylases.
per: Schofield, C, et al.
Publicat: (2005)

The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
per: Foxler, D, et al.
Publicat: (2012)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
per: Chen, R, et al.
Publicat: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
per: Chen, R, et al.
Publicat: (2014)

Prolyl hydroxylases and therapeutics.
per: Smith, T, et al.
Publicat: (2010)